Robert Bosch GmbH became the latest company to roll out a Covid-19 test, saying it can diagnose in less than 2.5 hours and help efforts to fight the outbreak.
The new test uses the Vivalytic molecular diagnostics platform made by Bosch’s health-care division. The device is already used in hospitals, laboratories and medical practices to identify a range of bacterial and viral diseases including influenza and pneumonia.
It will be available in Germany in April and sold in international markets, Bosch said. “Infected patients can be identified and isolated faster," Bosch Chief Executive Officer Volkmar Denner said Thursday in a statement.